China News Online, January 26 (Reporter Chen Jing) Since January 21, the West Hospital of Renji Hospital and Fudan University Cancer Hospital have implemented closed-loop management.
"Closed-loop management" has brought difficulties to hospitals for normal diagnosis and treatment, but these medical institutions have explored and made breakthroughs in diagnosis and treatment services in order to facilitate patients to obtain treatment as soon as possible.
In the western courtyard of Renji Hospital, Shanghai Jiaotong University School of Medicine, Ma Xiong, a well-known gastroenterologist and chief gastroenterologist, did not rest.
On the 26th, he used the new "Cloud Clinic" to treat patients from Ningbo Hospital of Renji Hospital.
Ma Xiong also viewed patients' CT and laboratory reports through wireless 5G video, and worked with local doctors to formulate a thorough treatment plan for patients.
After being quarantined for 14 days this time, Ma Xiong told reporters that he opened an outpatient clinic in Ningbo Hospital of Renji Hospital, and nearly 400 patient visits were delayed as a result.
It is understood that in Shanghai, online follow-up methods are relatively mature.
Ma Xiong said frankly that isolation has little effect on patients.
For patients in Ningbo, they cherish the opportunity to have a face-to-face consultation once a month.
Under "closed-loop management", a breast cancer patient who participated in a clinical trial in the Cancer Hospital of Fudan University was successfully enrolled in the group.
Photo courtesy of Cancer Hospital
How to do it?
After communicating with the Ningbo Hospital of Renji Hospital, Ma Xiong decided to explore a new type of "cloud outpatient" service: Under the premise that the local doctors take a consultation, Ma Xiong joins the consultation online through video to jointly provide patients with diagnosis and treatment plans.
Ningbo patient Ms. Qin happily said: "Through the'cloud clinic', I only need to come to the hospital to register by myself, and I don't have to trouble my family."
On the same day, the reporter learned from Fudan University Affiliated Tumor Hospital that under "closed-loop management", some personnel in charge of clinical trials were unable to arrive at their posts due to isolation, which hindered the medication process of clinical trials.
However, with the efforts of the hospital, a breast cancer patient who participated in a clinical trial was successfully enrolled in the group.
At the beginning of January, Aunt Zhang, a breast cancer patient, went to the Department of Oncology, Cancer Hospital for treatment due to a relapse after surgery.
She applied to join an international multi-center clinical trial.
According to the treatment plan, after Aunt Zhang was admitted to the hospital on the 19th and completed the examination, she planned to complete the first drug enrollment of the clinical trial on the 21st.
The hospital enters "closed loop management", and Aunt Zhang, who is eager to treat the disease, still hopes to continue to be enrolled in the group to complete follow-up treatment.
Professor Wu Jiong, deputy dean of the Cancer Hospital and director of the drug clinical trial institution, said: “After full consideration and evaluation, the hospital decided to do its best to complete the first drug entry for Aunt Zhang under the premise of strict prevention and control of the epidemic.”
The hospital overcame difficulties to implement the person in charge of each link of the clinical trial, and quickly completed the online training of each process. After a lot of stress, Aunt Zhang successfully accepted the first medication. According to the hospital, in the past two days, three other tumor patients who were enrolled in other clinical trials and stranded in Xuhui Hospital completed their medication. (Finish)